Breakthrough for Breast Cancer Patients: FDA Approves Kisqali for Early-Stage Treatment
The Food and Drug Administration expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat patients […]
Clinical research
Bernie Sanders Says $1,000 Ozempic Could Cost Under $100 to Produce
WASHINGTON — Sen. Bernie Sanders, I-Vt., renewed his criticism of drugmaker Novo Nordisk on Tuesday, claiming that the CEOs of major